AI Summary
We reviewed 8 live results for xeljanz and narrowed them down to the 3 options that look most worth comparing first.
The strongest themes across this short list are Pharmaceutical and Extended Release Tablets.
Compare xeljanz with TopFind
Comparison Table
Recommended
XELJANZ XR
Source: Pfizer (Thailand) Ltd.
Description
XELJANZ XR is the extended-release formulation of tofacitinib, delivered in 11 mg tablets for once-daily dosing. It is indicated for the treatment of inflammatory conditions like rheumatoid arthritis and psoriatic arthritis where consistent medicine levels are required.
Best for
Once Daily dosing, Long Term maintenance and Chronic inflammation management
Rating
XELJANZ
Source: Pfizer (Thailand) Ltd.
Description
XELJANZ is a prescription medicine containing tofacitinib, a Janus kinase (JAK) inhibitor used to treat adults with moderately to severely active rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis. It is available as 5 mg film-coated tablets and is registered with the Thai FDA.
Best for
Rheumatoid arthritis patients, Psoriatic arthritis, Hospital prescriptions and Official brand preference
Rating
Xeljanz (Tofacitinib)
Source: Pfizer Thailand
Description
Xeljanz is the innovator brand of tofacitinib registered in Thailand. It is available in 5 mg film-coated tablets and 11 mg extended-release (XR) formats for the treatment of rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis at major hospitals.
Best for
Patients in Thailand, Innovator drug preference, Insured medical treatments and Hospital Based pharmacy users
Rating
| Compare | XELJANZ XR | XELJANZ | Xeljanz (Tofacitinib) |
|---|---|---|---|
| Source | Pfizer (Thailand) Ltd. | Pfizer (Thailand) Ltd. | Pfizer Thailand |
| Description | XELJANZ XR is the extended-release formulation of tofacitinib, delivered in 11 mg tablets for once-daily dosing. It is indicated for the treatment of inflammatory conditions like rheumatoid arthritis and psoriatic arthritis where consistent medicine levels are required. | XELJANZ is a prescription medicine containing tofacitinib, a Janus kinase (JAK) inhibitor used to treat adults with moderately to severely active rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis. It is available as 5 mg film-coated tablets and is registered with the Thai FDA. | Xeljanz is the innovator brand of tofacitinib registered in Thailand. It is available in 5 mg film-coated tablets and 11 mg extended-release (XR) formats for the treatment of rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis at major hospitals. |
| Best for | Once Daily dosing, Long Term maintenance and Chronic inflammation management | Rheumatoid arthritis patients, Psoriatic arthritis, Hospital prescriptions and Official brand preference | Patients in Thailand, Innovator drug preference, Insured medical treatments and Hospital Based pharmacy users |
| Action | |||
| Rating |
AI Recommendation
If you want the most balanced option to start with, I recommend:
"XELJANZ XR from Pfizer (Thailand) Ltd.."
I picked this because Offers the convenience of once-daily dosing through its extended-release formulation, supported by Pfizer's official clinical standards.